![]() |
|
|
Vol. 30, Issue 3, 262-269, March 2002
Laboratory of Human Toxicology and Molecular Epidemiology,
Wadsworth Center, New York State Department of Health, Albany, New York
Polycyclic aromatic hydrocarbons (PAHs) and metals are often
environmental cocontaminants, yet there have been relatively few
studies of combined effects of PAHs and metals on cytochrome P450
(P450)-catalyzed metabolism. We examined the effects of
NaAsO2 in combination with benzo[a]pyrene
(BAP) on CYP1A1 and CYP1B1 in T-47D human breast cancer cells by using
estrogen metabolism as a probe of their activities. Exposure to BAP
caused elevated rates of the 2- and 4-hydroxylation pathways of
estrogen metabolism, indicating induction of both CYP1A1, an estradiol
2-hydroxylase, and CYP1B1, an estradiol 4-hydroxylase. BAP-induced
metabolism peaked 9 to 16 h after exposure and returned to
near-basal levels by 48 h. Concentration-response studies showed
maximal induction of the 2- and 4-hydroxylation pathways at 3 µM BAP;
higher levels caused reduced rates of metabolism due to inhibition of
CYP1A1 and CYP1B1. NaAsO2 caused pronounced decreases in
the induction of CYP1A1 and CYP1B1 by 3 µM BAP because cotreatment
with 10 µM NaAsO2 inhibited the rates of the 2- and
4-hydroxylation pathways by 86 and 92%, respectively. Western
immunoblots showed diminished levels of BAP-induced CYP1A1 by
coexposure to NaAsO2. The levels of the CYP1A1 and CYP1B1
mRNAs induced by BAP were not significantly affected by coexposure to
NaAsO2; however, heme oxygenase 1 mRNA levels were markedly
induced by coexposure to BAP and NaAsO2. These results
indicate a post-transcriptional inhibitory effect of arsenite on the
expression of CYP1A1 and CYP1B1 in T-47D cells, possibly resulting from
reduced heme availability.
This article has been cited by other articles:
![]() |
T. L. Noreault, V. E. Kostrubsky, S. G. Wood, R. C. Nichols, S. C. Strom, H. W. Trask, S. A. Wrighton, R. M. Evans, J. M. Jacobs, P. R. Sinclair, et al. ARSENITE DECREASES CYP3A4 AND RXR{alpha} IN PRIMARY HUMAN HEPATOCYTES Drug Metab. Dispos., July 1, 2005; 33(7): 993 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gharavi and A. O. S. El-Kadi tert-BUTYLHYDROQUINONE IS A NOVEL ARYL HYDROCARBON RECEPTOR LIGAND Drug Metab. Dispos., March 1, 2005; 33(3): 365 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Port, K. Yamaguchi, B. Du, M. De Lorenzo, M. Chang, P. M. Heerdt, L. Kopelovich, C. B. Marcus, N. K. Altorki, K. Subbaramaiah, et al. Tobacco smoke induces CYP1B1 in the aerodigestive tract Carcinogenesis, November 1, 2004; 25(11): 2275 - 2281. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uno, T. P. Dalton, S. Derkenne, C. P. Curran, M. L. Miller, H. G. Shertzer, and D. W. Nebert Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation Mol. Pharmacol., May 1, 2004; 65(5): 1225 - 1237. [Abstract] [Full Text] |
||||
![]() |
T. Almahmeed, J. O. Boyle, E. G. Cohen, J. F. Carew, B. Du, N. K. Altorki, L. Kopelovich, J.-L. Fang, P. Lazarus, K. Subbaramaiah, et al. Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract Carcinogenesis, May 1, 2004; 25(5): 793 - 799. [Full Text] [PDF] |
||||